What is the generic name?

TRALOKINUMAB-LDRM

What is the Trade Name for TRALOKINUMAB-LDRM?

Adbry

What are the Indications for TRALOKINUMAB-LDRM?

• 1 INDICATIONS AND USAGE ADBRY is indicated for the treatment of moderate-to-severe atopic dermatitis in adult patients whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. ADBRY can be used with or without topical corticosteroids. ADBRY is an interleukin-13 antagonist indicated for the treatment of moderate-to-severe atopic dermatitis in adult patients whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. ADBRY can be used with or without topical corticosteroids. ( 1 )

References: https://open.fda.gov/